CCND1 and breast carcinoma: Notably, significantly lower levels of cyclin D1 protein were observed in all four breast cancer cell lines treated with phenformin (Fig 3), which suggested that phenformin might regulate the cell cycle of breast cancer cells by modulating cyclin D1.